Atherogenic Index of Plasma an Indicator for Predicting Cardiovascular Risk in Addition to Endothelial Dysfunction in Type 2 Diabetic Subjects

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 6

Abstract

ABSTRACT Introduction: Prevalence of Cardiovascular Disease (CVD) in diabetic subjects is higher than that in the general population. Dyslipidaemia is a known atherogenic factor which causes vascular complications in both general and diabetic population. Antherogenic Index of Plasma (AIP) is the ratio of triglyceride to HDL, which is a major factor for detecting cardiovascular risk. Endothelial Dysfunction (ED) is the primary stage for the development of atherosclerosis and vascular complications. Aim: To estimate whether AIP will be a strong indicator for predicting cardiovascular risk in addition to endothelial dysfunction in type 2 diabetes mellitus. Materials and Methods: The study was conducted on 80 subjects with age group 38-60 years. Among these subjects 40 were type 2 diabetic subjects and remaining 40 were age and sex matched healthy controls. Blood sugar, lipid profile were measured by using well established methods in fully autoanalyser. Lipoprotein ratios were calculated by using lipid profile values in Microsoft Excel. AIP was calculated by using formula log (TG/HDL-c). Nitric Oxide (NO) was estimated by kinetic cadmium reduction method in spectrophotometer. Statistical analysis was done by using SPSS software version 21.0, “Kruskal-Wallis” test was performed for variables between the study groups. Results: Significantly high levels of Triglyceride (TG) and LDL (151.75±62.38 and 181.70±45.72) were observed in type 2 diabetic subjects than healthy controls (121.15±72.72 and 119.13±34.13). The study also observed significantly high levels of TG/HDL and LDL/HDL ratio’s and AIP in type 2 diabetic subjects. Significantly lower level of NO was observed in diabetic subjects; NO is negatively correlated with AIP, TG, LDL, TG/HDL and LDL/HDL. Conclusion: We found negative correlation of AIP with NO. Hence, estimation of NO in addition to AIP can be a strong indicator for predicting CVD in type 2 diabetic subjects.

Authors and Affiliations

Siva Prasad Palem, Philips Abraham

Keywords

Related Articles

Segregation of Patients for Intrapartum Monitoring, using Robson’s Classification

Introduction: Monitoring labour by intermittent or continuous foetal heart rate monitoring has been discussed widely in literature. Robson’s classification has categorized pregnant women in ten groups. The study proposes...

Association between Socioeconomic Status and Diabetes Mellitus: The National Socioeconomics Survey, 2010 and 2012

Introduction: The prevalence of Diabetes Mellitus (DM) is increasing, globally. However, studies on the association between Socioeconomic Status (SES) factors and DM have mostly been conducted in specific areas with rath...

Natural Killer Cells: An Insight into its Role in Pregnancy

ABSTRACT Tight regulation of immunotolerance at fetomaternal interface facilitates the survival of allogeneic embryo. Natural Killer (NK) cells are immune cells capable of lysing the target cells via the release of cytol...

Bilateral Radicular Dens Invaginatus in Mandibular First Premolars-Report of Two Rare Cases

ABSTRACT Dens invaginatus is a developmental dental anomaly which is clinically seen as a furrow on the palatal aspect of the tooth either limiting to the coronal pulp or extending to the radicular apex. It occurs most c...

Comparison of Antiemetic Effectiveness of Palonosetron Versus Ondansetron in Patients on Cancer Chemotherapy: A Prospective Observational Study in South Indians

Introduction: Chemotherapy Induced Nausea and Vomiting (CINV) is the most distressing side effect of cancer chemotherapy. It can seriously produce an impact on patient's quality of life. Prevention of CINV is far more ef...

Download PDF file
  • EP ID EP522427
  • DOI 10.7860/JCDR/2018/31834.11690
  • Views 26
  • Downloads 0

How To Cite

Siva Prasad Palem, Philips Abraham (2018). Atherogenic Index of Plasma an Indicator for Predicting Cardiovascular Risk in Addition to Endothelial Dysfunction in Type 2 Diabetic Subjects. Journal of Clinical and Diagnostic Research, 12(6), 21-24. https://europub.co.uk/articles/-A-522427